Get full access to one story every week, and to summaries of all other stories. Just create a free account

Seema Singh


Seema has over two decades of experience in journalism. Before starting The Ken, Seema wrote “Myth Breaker: Kiran Mazumdar-Shaw and the Story of Indian Biotech”, published by HarperCollins in May 2016. Prior to that, she was a senior editor and bureau chief for Bangalore with Forbes India, and before that she wrote for Mint. Seema has written for numerous international publications like IEEE-Spectrum, New Scientist, Cell and Newsweek. Seema is a Knight Science Journalism Fellow from the Massachusetts Institute of Technology and a MacArthur Foundation Research Grantee.

125 Articles published

Top Comments by Seema Singh

Jahangir Mohammed sold his IoT startup for US$1.4B. Now he wants us all to have a digital twin

Vandana, The story seems one-sided to you because I did not quote a bunch of startups trying to do diet-related diabetes reversal. There's a reason for that. I've followed most such startups' work for many years and I did not feel the need to bring those examples in. This is a different technology. None of those startups have the creds of publishing in peer-reviewed journals. And this is NOT a Keto programme, whereas Virta is a Keto diet programme. On its website, Virta lists 3-4 publications. (Please check them out). They are ALL non-RCT studies, which do not count in the scientific world. I'm afraid I don't understand what depth you were looking for in a story that is about a very different technology which has no real peers in its approach. That said, I take your feedback and will do better next time in such stories.

Seema Singh

Stories by Seema Singh